Participants with mild, moderate, or severe pain following total hip arthroplasty. A sub-study of the PANSAID trial on paracetamol and ibuprofen for postoperative pain treatment.

ibuprofen integrated pain score and opioid use paracetamol postoperative pain prediction of pain total hip arthroplasty

Journal

Scandinavian journal of pain
ISSN: 1877-8879
Titre abrégé: Scand J Pain
Pays: Germany
ID NLM: 101520867

Informations de publication

Date de publication:
27 04 2021
Historique:
received: 31 08 2020
accepted: 09 11 2020
entrez: 13 8 2021
pubmed: 14 8 2021
medline: 1 12 2021
Statut: epublish

Résumé

In this sub-study of the 'Paracetamol and Ibuprofen in Combination' (PANSAID) trial, in which participants were randomised to one of four different non-opioids analgesic regimen consisting of paracetamol, ibuprofen, or a combination of the two after planned primary total hip arthroplasty, our aims were to investigate the distribution of participants' pain (mild, moderate or severe), integrate opioid use and pain to a single score (Silverman Integrated Approach (SIA)-score), and identify preoperative risk factors for severe pain. We calculated the proportions of participants with mild (VAS 0-30 mm), moderate (VAS 31-60 mm) or severe (VAS 61-100 mm) pain and the SIA-scores (a sum of rank-based percentage differences from the mean rank in pain scores and opioid use, ranging from -200 to 200%). Using logistic regression with backwards elimination, we investigated the association between severe pain and easily obtainable preoperative patient characteristics. Among 556 participants from the modified intention-to-treat population, 33% (95% CI: 26-42) (Group Paracetamol + Ibuprofen (PCM + IBU)), 28% (95% CI: 21-37) (Group Paracetamol (PCM)), 23% (95% CI: 17-31) (Group Ibuprofen (IBU)), and 19% (95% CI: 13-27) (Group Half Strength-Paracetamol + Ibuprofen (HS-PCM + IBU)) experienced mild pain 6 h postoperatively during mobilisation. Median SIA-scores during mobilisation were: Group PCM + IBU: -48% (IQR: -112 to 31), Group PCM: 40% (IQR: -31 to 97), Group IBU: -5% (IQR: -57 to 67), and Group HS-PCM + IBU: 6% (IQR: -70 to 74) (overall difference: p=0.0001). Use of analgesics before surgery was the only covariate associated with severe pain (non-opioid: OR 0.50, 95% CI: 0.29-0.82, weak opioid 0.56, 95% CI: 0.28-1.16, reference no analgesics before surgery, p=0.02). Only one third of participants using paracetamol and ibuprofen experienced mild pain after total hip arthroplasty and even fewer experienced mild pain using each drug alone as basic non-opioid analgesic treatment. We were not able, in any clinically relevant way, to predict severe postoperative pain. A more extensive postoperative pain regimen than paracetamol, ibuprofen and opioids may be needed for a large proportion of patients having total hip arthroplasty. SIA-scores integrate pain scores and opioid use for the individual patient and may add valuable information in acute pain research.

Identifiants

pubmed: 34387964
pii: sjpain-2020-0141
doi: 10.1515/sjpain-2020-0141
doi:

Substances chimiques

Analgesics, Non-Narcotic 0
Acetaminophen 362O9ITL9D
Ibuprofen WK2XYI10QM

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

384-392

Informations de copyright

© 2020 Walter de Gruyter GmbH, Berlin/Boston.

Références

Sommer, M, de Rijke, JM, van Kleef, M, Kessels, AG, Peters, ML, Geurts, JW, et al.. The prevalence of postoperative pain in a sample of 1490 surgical inpatients. Eur J Anaesthesiol 2008;25:267–74. https://doi.org/10.1017/S0265021507003031.
Moore, RA, Straube, S, Aldington, D. Pain measures and cut-offs – ‘no worse than mild pain’ as a simple, universal outcome. Anaesthesia 2013;68:400–12. https://doi.org/10.1111/anae.12148.
Barden, J, Edwards, JE, Mason, L, McQuay, HJ, Moore, RA. Outcomes in acute pain trials: systematic review of what was reported? Pain 2004;109:351–6. https://doi.org/10.1016/j.pain.2004.01.032.
Breivik, H, Borchgrevink, PC, Allen, SM, Rosseland, LA, Romundstad, L, Hals, EK, et al.. Assessment of pain. Br J Anaesth 2008;101:17–24. https://doi.org/10.1093/bja/aen103.
Dai, F, Silverman, DG, Chelly, JE, Li, J, Belfer, I, Qin, L. Integration of pain score and morphine consumption in analgesic clinical studies. J Pain 2013;14:767–77.e8. https://doi.org/10.1016/j.jpain.2013.04.004.
Silverman, DG, O’Connor, TZ, Brull, SJ. Integrated assessment of pain scores and rescue morphine use during studies of analgesic efficacy. Anesth Analg 1993;77:168–70.
Andersen, LPK, Gogenur, I, Torup, H, Rosenberg, J, Werner, MU. Assessment of postoperative analgesic drug efficacy: method of data analysis is critical. Anesth Analg 2017;125:1008–13. https://doi.org/10.1213/ANE.0000000000002007.
Benzon, HT, Mascha, EJ, Wu, CL. Studies on postoperative analgesic efficacy: focusing the statistical methods and broadening outcome measures and measurement tools. Anesth Analg 2017;125:726–8. https://doi.org/10.1213/ANE.0000000000002218.
Brummett, CM, Clauw, DJ. Flipping the paradigm: from surgery-specific to patient-driven perioperative analgesic algorithms. Anesthesiology 2015;122:731–3. https://doi.org/10.1097/ALN.0000000000000598.
Thybo, KH, Hägi-Pedersen, D. Individual pain response and prediction of pain: preplanned sub-study of the PANSAID trial; 2017. Available from: https://docs.google.com/viewerng/viewer?url=http://pansaid.dk/onewebmedia/Protocol_Individual%2520pain%2520response%2520and%2520prediction_FINAL_version%25201.pdf [Accessed 15 Aug 2018].
Thybo, KH, Hagi-Pedersen, D, Dahl, JB, Wetterslev, J, Nersesjan, M, Jakobsen, JC, et al.. Effect of combination of paracetamol (acetaminophen) and ibuprofen vs. either alone on patient-controlled morphine consumption in the first 24 h after total hip arthroplasty: the PANSAID randomized clinical trial. J Am Med Assoc 2019;321:562–71. https://doi.org/10.1001/jama.2018.22039.
Thybo, KH, Jakobsen, JC, Hagi-Pedersen, D, Pedersen, NA, Dahl, JB, Schroder, HM, et al.. PANSAID-paracetamol and NSAID in combination: detailed statistical analysis plan for a randomised, blinded, parallel, four-group multicentre clinical trial. Trials 2017;18:465. https://doi.org/10.1186/s13063-017-2203-1.
Thybo, KH, Hagi-Pedersen, D, Wetterslev, J, Dahl, JB, Schroder, HM, Bulow, HH, et al.. PANSAID-paracetamol and NSAID in combination: study protocol for a randomised trial. Trials 2017;18:11. https://doi.org/10.1186/s13063-016-1749-7.
Kalkman, CJ, Visser, K, Moen, J, Bonsel, GJ, Grobbee, DE, Moons, KG. Preoperative prediction of severe postoperative pain. Pain 2003;105:415–23. https://doi.org/10.1016/S0304-3959(03)00252-5.
Liu, SS, Buvanendran, A, Rathmell, JP, Sawhney, M, Bae, JJ, Moric, M, et al.. Predictors for moderate to severe acute postoperative pain after total hip and knee replacement. Int Orthop 2012;36:2261–7. https://doi.org/10.1007/s00264-012-1623-5.
Mei, W, Seeling, M, Franck, M, Radtke, F, Brantner, B, Wernecke, KD, et al.. Independent risk factors for postoperative pain in need of intervention early after awakening from general anaesthesia. Eur J Pain 2010;14:149 e1–7. https://doi.org/10.1016/j.ejpain.2009.03.009.
Knowledge Translation Program. Evidence-based medicine toolbox; 2017. Available from: https://ebm-tools.knowledgetranslation.net/calculator/converter/ [Accessed 28 Jan 2020].
Altman, DG, Royston, P. The cost of dichotomising continuous variables. BMJ 2006;332:1080. https://doi.org/10.1136/bmj.332.7549.1080.
Kehlet, H, Dahl, JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003;362:1921–8. https://doi.org/10.1016/S0140-6736(03)14966-5.
Mathiesen, O, Wetterslev, J, Kontinen, VK, Pommergaard, HC, Nikolajsen, L, Rosenberg, J, et al.. Adverse effects of perioperative paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol Scand 2014;58:1182–98. https://doi.org/10.1111/aas.12380.
Dawson, NV, Weiss, R. Dichotomizing continuous variables in statistical analysis: a practice to avoid. Med Decis Making 2012;32:225–6. https://doi.org/10.1177/0272989X12437605.
Ragland, DR. Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint. Epidemiology 1992;3:434–40. https://doi.org/10.1097/00001648-199209000-00009.
McGlothlin, AE, Lewis, RJ. Minimal clinically important difference: defining what really matters to patients. J Am Med Assoc 2014;312:1342–3. https://doi.org/10.1001/jama.2014.13128.
Tan, SG, Cyna, AM. Subjective and objective experience of pain. Anaesthesia 2013;68:785–6. https://doi.org/10.1111/anae.12335.
Werner, MU, Mjobo, HN, Nielsen, PR, Rudin, A. Prediction of postoperative pain: a systematic review of predictive experimental pain studies. Anesthesiology 2010;112:1494–502. https://doi.org/10.1097/ALN.0b013e3181dcd5a0.

Auteurs

Luma Mahmoud Issa (LM)

Department of Anaesthesiology, Centre for Anaesthesiological Research, Zealand University Hospital, Køge, Denmark.

Kasper Højgaard Thybo (KH)

Department of Anaesthesiology, Centre for Anaesthesiological Research, Zealand University Hospital, Køge, Denmark.

Daniel Hägi-Pedersen (D)

Department of Anaesthesiology, Head of Research, Næstved, Slagelse and Ringsted Hospitals, Næstved, Denmark.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Jørn Wetterslev (J)

Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark.

Janus Christian Jakobsen (JC)

Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Copenhagen Trial Unit, Rigshospitalet, Copenhagen, Denmark.
Department of Cardiology, Holbæk Hospital, Holbæk, Denmark.

Søren Overgaard (S)

Department of Orthopaedic Surgery and Traumatology, Orthopaedic Research Unit, Odense University Hospital, Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Ole Mathiesen (O)

Department of Anaesthesiology, Centre for Anaesthesiological Research, Zealand University Hospital, Køge, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH